Title | Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected [electronic resource] : Proceedings of the jubilee Twenty-Fifth International Symposium on Blood Transfusion, Groningen, 2000, Organized by the Sanquin Division Blood Bank Noord Nederland / edited by C. Th. Smit Sibinga, J. D. Cash |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 2001 |
Connect to | http://dx.doi.org/10.1007/978-1-4615-1735-1 |
Descript | XIII, 304 p. online resource |
I. Blood Supply Systems and Organisation -- Blood Transfusion: Quo Vadis? Customer Orientation as the Leading Principal for Blood Banks in the Future -- Community Involvement: The Development, the Past โ the Present and the Future of Blood Donations as a Form of Community Involvement -- Structure and Commitments โ Blood Supply Systems and Organization -- Applying Decision Analysis to Transfusion Medicine in the Real World to Improve Transfusion Safety -- Cost-Effectiveness of HIV NAT Screening for Dutch Donors -- Legal and Regulatory Aspects of Blood Transfusion -- Discussion -- II. Technical and Pharmaceutical Developments -- Freezing and Vitrification of Red Cells, Recollections and Predictions -- Plasma Fractionation -- Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Labile Blood Components by Using Nucleic Acid Targeted Methods -- Alternatives to Human Blood Resources -- Discussion -- III. Quality Principles and Risk Management -- Quality Systems and Management: 2000 Where Have We Been and Where Are We Going? -- Traceability and Coding Principles -- Quality Principles and Risk Management: Automation and Documentation -- Haemovigilance -- Human Resources: Teaching and Training in Transfusion Medicine -- Discussion -- IV. Transfusion Medicine at the Bedside -- The Epidemiology of Blood Component Transfusion in South Eastern Scotland, 1990 to 1997 -- Contributions of Meta-Analysis to Transfusion Medicine -- Immunomodulation: Facts and Interpretations -- Development and Implementation of New Cellular Therapies -- Transfusion Medicine and the Development of Gene Therapy -- Making Policy in the 2000s -- Discussion